Preview Mode Links will not work in preview mode

Eagle's Eye View: Your Weekly CV Update From ACC.org


Sep 3, 2019

In this special episode of the View, Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss Day 3 of ESC Congress 2019, including rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease (AFIRE); effects of sacubitril-valsartan compared with enalapril on arterial hemodynamics and cardiac remodeling in patients with heart failure and reduced ejection fraction (EVALUATE-HF, PROVE-HF); using cardiolinguistics and artificial intelligence to reframe typical and atypical angina (HERMES); and the combined effect of lower LDL-C and lower systolic blood pressure on the lifetime risk of cardiovascular disease (LDL SBP).